Lipocine Inc.
LPCN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $26,054 | $14,702 | $33,806 | $55,638 |
| - Cash | $6,206 | $4,772 | $3,148 | $2,951 |
| + Debt | $439 | $17 | $0 | $2,311 |
| Enterprise Value | $20,287 | $9,948 | $30,657 | $54,998 |
| Revenue | $11,198 | -$2,851 | $500 | $16,141 |
| % Growth | 492.8% | -670.2% | -96.9% | – |
| Gross Profit | $11,198 | -$13,026 | -$8,057 | $8,475 |
| % Margin | 100% | 456.9% | -1,611.4% | 52.5% |
| EBITDA | -$1,114 | -$17,902 | -$10,721 | -$431 |
| % Margin | -9.9% | 628% | -2,144.3% | -2.7% |
| Net Income | $8 | -$16,352 | -$10,759 | -$634 |
| % Margin | 0.1% | 573.6% | -2,151.7% | -3.9% |
| EPS Diluted | -0.002 | -3.14 | -2.05 | -0.12 |
| % Growth | 99.9% | -53.2% | -1,608.3% | – |
| Operating Cash Flow | -$1,221 | -$11,866 | -$11,969 | -$4,411 |
| Capital Expenditures | -$90 | -$13 | -$134 | -$8 |
| Free Cash Flow | -$1,311 | -$11,879 | -$12,103 | -$4,419 |